Arcellx Inc (ACLX) Ownership

32.70 ↓0.67 (-2.01%)
As of February 3, 2023, 3:59pm EST.

Institutional Ownership

NEA Management Company, LLC is the biggest individual institutional holder of Arcellx Inc (ACLX), owning a total of 6.8 million shares. Combined, the top 22 institutional holders of ACLX own 87.99% of the company with a total of 38.6 million shares.

In the latest ownership report on September 30th 2022, the top 22 institutional holders increased their combined ownership of ACLX by 5.9 million shares. 11 institutions bought 7,439,202 total additional shares and increased their ownership by an average of 157.58%. However 5 institutions sold 1,573,856 total shares and decreased their ownership by an average of 14.7%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Arcellx increased by a net total of 5,865,346 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
NEA Management Company, LLC15.393%0.000%6,750,26402022-09-30
SR ONE CAPITAL MANAGEMENT, LP12.542%0.000%5,500,00702022-09-30
Novo A/S7.278%-20.538%3,191,878-825,0002022-09-30
Cormorant Asset Management, LLC6.953%99.946%3,049,1731,524,1732022-09-30
Perceptive Advisors LLC5.622%115.887%2,465,4051,323,4152022-09-30
Suvretta Capital Management, LLC5.130%-8.946%2,249,533-221,0262022-09-30
BlackRock Inc4.119%199.763%1,806,1031,203,5922022-09-30
Citadel Advisors Llc3.981%-1.324%1,745,970-23,4302022-09-30
State Street Corporation3.452%761.137%1,514,0251,338,2082022-09-30
AJU IB Investment Co Ltd3.149%0.000%1,380,89002022-09-30
Soleus Capital Management, L.P.2.827%36.293%1,239,913330,1742022-09-30
Vanguard Group Inc2.817%85.190%1,235,387568,2962022-09-30
HHG PLC2.650%-7.388%1,162,109-92,7002022-09-30
Samsara BioCapital, LLC2.426%0.000%1,063,83502022-09-30
FMR Inc1.798%26.446%788,668164,9502022-09-30
Clough Capital Partners, LP1.719%-35.323%753,833-411,7002022-09-30
Lord, Abbett & Co LLC1.464%26.660%642,156135,1622022-09-30
Adage Capital Partners Gp LLC1.202%0.000%526,90402022-09-30
Geode Capital Management, LLC1.196%174.214%524,593333,2852022-09-30
TimesSquare Capital Management, LLC0.869%0.000%381,010381,0102022-09-30
Charles Schwab Investment Management Inc0.463%207.789%202,839136,9372022-09-30

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
NEA Management Company, LLC15.393%0.000%6,750,26402022-09-30
SR ONE CAPITAL MANAGEMENT, LP12.542%0.000%5,500,00702022-09-30
Novo A/S7.278%-20.538%3,191,878-825,0002022-09-30
Cormorant Asset Management, LLC6.953%99.946%3,049,1731,524,1732022-09-30
Perceptive Advisors LLC5.622%115.887%2,465,4051,323,4152022-09-30
Suvretta Capital Management, LLC5.130%-8.946%2,249,533-221,0262022-09-30
BlackRock Inc4.119%199.763%1,806,1031,203,5922022-09-30
Citadel Advisors Llc3.981%-1.324%1,745,970-23,4302022-09-30
State Street Corporation3.452%761.137%1,514,0251,338,2082022-09-30
AJU IB Investment Co Ltd3.149%0.000%1,380,89002022-09-30
Soleus Capital Management, L.P.2.827%36.293%1,239,913330,1742022-09-30
Vanguard Group Inc2.817%85.190%1,235,387568,2962022-09-30
HHG PLC2.650%-7.388%1,162,109-92,7002022-09-30
Samsara BioCapital, LLC2.426%0.000%1,063,83502022-09-30
FMR Inc1.798%26.446%788,668164,9502022-09-30
Clough Capital Partners, LP1.719%-35.323%753,833-411,7002022-09-30
Lord, Abbett & Co LLC1.464%26.660%642,156135,1622022-09-30
Adage Capital Partners Gp LLC1.202%0.000%526,90402022-09-30
Geode Capital Management, LLC1.196%174.214%524,593333,2852022-09-30
Balyasny Asset Management LLC0.941%172.745%412,570261,3042022-06-30
TimesSquare Capital Management, LLC0.869%0.000%381,010381,0102022-09-30
Charles Schwab Investment Management Inc0.463%207.789%202,839136,9372022-09-30

Mutual Fund Ownership

SPDR® S&P Biotech ETF is the biggest individual fund holder of Arcellx Inc (ACLX), owning a total of 1.1 million shares. Combined, the top 24 mutual fund holders of ACLX own 17.44% of the company with a total of 7.6 million shares.

In the latest ownership report on December 31st 2022, the top 24 fund holders increased their combined ownership of ACLX by 760 thousand shares. 4 funds bought 785,400 total additional shares and increased their ownership by an average of 368.83%. However 3 funds sold 25,196 total shares and decreased their ownership by an average of 3.3%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Arcellx increased by a net total of 760,204 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF2.408%-0.872%1,055,828-9,2822022-12-31
Vanguard Total Stock Mkt Idx Inv2.000%19.674%877,147144,2002022-12-31
Belfius Equities Cure C Cap0.889%254.546%390,000280,0002022-12-31
Candriam Global Equities Oncology0.889%1,200.000%390,000360,0002022-12-31
Vanguard Extended Market Index Investor0.846%-0.044%371,201-1632022-12-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.363%-8.995%159,349-15,7512022-12-31
State St Russell Sm Cap® Indx NL Cl C0.253%1.094%110,8611,2002022-12-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF2.408%-0.872%1,055,828-9,2822022-12-31
Vanguard Total Stock Mkt Idx Inv2.000%19.674%877,147144,2002022-12-31
Vanguard Instl Ttl Stck Mkt Idx Tr1.664%48.420%729,809238,0892022-09-30
iShares Russell 2000 ETF1.529%-0.828%670,382-5,6002022-12-30
Fidelity® Select Biotechnology1.381%0.000%605,40002022-11-30
Belfius Equities Cure C Cap0.889%254.546%390,000280,0002022-12-31
Candriam Global Equities Oncology0.889%1,200.000%390,000360,0002022-12-31
Vanguard Extended Market Index Investor0.846%-0.044%371,201-1632022-12-31
Clough Global Opportunities0.751%-14.990%329,493-58,1002022-09-30
iShares Russell 2000 Value ETF0.708%0.000%310,63702022-12-30
Fidelity® Small Cap Index0.535%2.556%234,3785,8412022-10-31
iShares Biotechnology ETF0.423%-0.301%185,597-5602022-12-30
Lord Abbett Micro Cap Growth I0.407%-12.442%178,532-25,3702022-11-30
Clough Global Equity0.376%-15.011%164,764-29,1002022-09-30
State St Russell Sm/Mid Cp® Indx NL Cl C0.363%-8.995%159,349-15,7512022-12-31
Fidelity® Select Pharmaceuticals Port0.358%0.000%157,10002022-10-31
Fidelity® Extended Market Index0.305%0.000%133,71502022-11-30
Empower Small Cap Growth/TimesSquare SP0.277%0.000%121,300121,3002022-09-30
Schwab US Small-Cap ETF™0.262%0.000%114,77502022-12-30
State St Russell Sm Cap® Indx NL Cl C0.253%1.094%110,8611,2002022-12-31
Direxion Daily S&P Biotech Bull 3X ETF0.224%7.244%98,2486,6362022-12-29
NT R2000 Value Index Fund - NL0.212%198.850%93,07161,9282022-09-30
NT R2000 Index Fund - NL0.194%198.860%84,96956,5382022-09-30
1290 VT Micro Cap K0.183%7.992%80,0735,9262022-09-30

Discussions

Please log in or register to share your thoughts.